Scalper1 News
An update on a patent dispute sent two drug stocks in opposite directions Tuesday. The Medicines Company (MDCO) saw analysts cut its price target, leading to a 15% drop in its shares in morning trading on the stock market today, after the company reported bad news in its patent dispute with Hospira (HSP) late Monday. Hospira stock was up 1.5% in morning trading Tuesday. The case concerns Hospira’s attempt to bring out a generic version of Scalper1 News
Scalper1 News